Skip to main content
. 2022 Jan 25;27:1036–1055. doi: 10.1016/j.omtn.2022.01.018

Figure 8.

Figure 8

The relationships between six PRLs and drug sensitivity

(A–D) The differences of sensitivity of patients to cisplatin (A), doxorubicin (B), etoposide (C), and paclitaxel (D) in high- and low-risk groups. (E) Correlation between six PRLs and chemotherapeutic drugs is shown.